281 related articles for article (PubMed ID: 24300133)
21. Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
Alammari AH; Shoieb SM; Maayah ZH; El-Kadi AOS
J Pharm Sci; 2020 Jul; 109(7):2321-2335. PubMed ID: 32240690
[TBL] [Abstract][Full Text] [Related]
22. Repurposing Resveratrol and Fluconazole To Modulate Human Cytochrome P450-Mediated Arachidonic Acid Metabolism.
El-Sherbeni AA; El-Kadi AO
Mol Pharm; 2016 Apr; 13(4):1278-88. PubMed ID: 26918316
[TBL] [Abstract][Full Text] [Related]
23. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid.
Nithipatikom K; Grall AJ; Holmes BB; Harder DR; Falck JR; Campbell WB
Anal Biochem; 2001 Nov; 298(2):327-36. PubMed ID: 11700990
[TBL] [Abstract][Full Text] [Related]
24. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
[TBL] [Abstract][Full Text] [Related]
25. Testosterone, cytochrome P450, and cardiac hypertrophy.
Thum T; Borlak J
FASEB J; 2002 Oct; 16(12):1537-49. PubMed ID: 12374776
[TBL] [Abstract][Full Text] [Related]
26. Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.
El-Sherbeni AA; Aboutabl ME; Zordoky BN; Anwar-Mohamed A; El-Kadi AO
AAPS J; 2013 Jan; 15(1):112-22. PubMed ID: 23139020
[TBL] [Abstract][Full Text] [Related]
27. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
Knickle LC; Bend JR
Mol Pharmacol; 1994 Jun; 45(6):1273-80. PubMed ID: 8022420
[TBL] [Abstract][Full Text] [Related]
28. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
[TBL] [Abstract][Full Text] [Related]
29. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
30. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
Zordoky BN; El-Kadi AO
Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140
[TBL] [Abstract][Full Text] [Related]
31. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?
Westphal C; Konkel A; Schunck WH
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):99-108. PubMed ID: 21945326
[TBL] [Abstract][Full Text] [Related]
32. Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet.
Zhou Y; Lin S; Chang HH; Du J; Dong Z; Dorrance AM; Brands MW; Wang MH
Am J Hypertens; 2005 Apr; 18(4 Pt 1):530-7. PubMed ID: 15831364
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line.
Tse MM; Aboutabl ME; Althurwi HN; Elshenawy OH; Abdelhamid G; El-Kadi AO
Vascul Pharmacol; 2013; 58(5-6):363-73. PubMed ID: 23466634
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
Shoieb SM; El-Kadi AOS
Mol Cell Biochem; 2020 Aug; 471(1-2):165-176. PubMed ID: 32533462
[TBL] [Abstract][Full Text] [Related]
35. Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
Shoieb SM; Alammari AH; Levasseur J; Silver H; Dyck JRB; El-Kadi AOS
J Cardiovasc Pharmacol; 2022 Jun; 79(6):833-845. PubMed ID: 35266922
[TBL] [Abstract][Full Text] [Related]
36. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.
Maayah ZH; El-Kadi AO
Arch Toxicol; 2016 Jan; 90(1):119-36. PubMed ID: 26525395
[TBL] [Abstract][Full Text] [Related]
37. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
38. Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites.
Maayah ZH; Elshenawy OH; Althurwi HN; Abdelhamid G; El-Kadi AO
J Pharmacol Toxicol Methods; 2015; 71():33-41. PubMed ID: 25454080
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension.
Wang MH; Smith A; Zhou Y; Chang HH; Lin S; Zhao X; Imig JD; Dorrance AM
Hypertension; 2003 Oct; 42(4):594-9. PubMed ID: 12939236
[TBL] [Abstract][Full Text] [Related]
40. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited.
Gross GJ; Falck JR; Gross ER; Isbell M; Moore J; Nithipatikom K
Cardiovasc Res; 2005 Oct; 68(1):18-25. PubMed ID: 15993870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
